(Q73759249)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Dopaminergic function and the cortisol response to dexamethasone in psychotic depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

1 reference

F Duval

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M C Mokrani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M A Crocq

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P E Bailey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T S Diep

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H Correa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J P Macher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

Progress in Neuro-Psychopharmacology & Biological Psychiatry

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

207-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Blunted response of growth hormone to clonidine and apomorphine in endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Dexamethasone increases plasma free dopamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Elevated plasma homovanillic acid in depressed females with melancholia and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Peripheral distribution of free dopamine and its metabolites in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Fluvoxamine alone in the treatment of delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Apomorphine injection stimulates beta-endorphin, adrenocorticotropin, and cortisol release in healthy man

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Pathophysiology of HPA axis abnormalities in patients with major depression: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Apomorphine in the evaluation of dopaminergic function in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

DST and TRH stimulation test in mood disorder subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Plasma catecholamine metabolites in subtypes of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Basic principles of ROC analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Multihormonal responses to apomorphine in mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

DST studies in psychotic depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Suicidal behavior and growth hormone response to apomorphine test

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Antiglucocorticoid treatments in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

The dexamethasone suppression test in psychotic versus non-psychotic endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Effects of glucocorticoids on plasma catecholamines in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

A corticosteroid/dopamine hypothesis for psychotic depression and related states

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Delusional versus non-delusional depression: Neurochemical differences

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Dexamethasone increases plasma HVA but not MHPG in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Specificity of plasma HVA response to dexamethasone in psychotic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Dissociation between pituitary and adrenal suppression to dexamethasone in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2899%2900098-6

7 January 2021

10.1016/S0278-5846(99)00098-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10800744%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference